Literature DB >> 1520521

Carbohydrates in oral epithelia and secretions: variation with cellular differentiation.

U Mandel1.   

Abstract

The oral mucosa has been extensively studied in the past, and has thus become a model for demonstration of dynamic changes in cellular glycosylation and many other cell products such as keratins in relation to epithelial differentiation. The extensive knowledge of the glycosylation pattern in normal cells is instrumental in evaluation of the often occurring aberrant glycosylation of carcinoma cells. The emerging developments in antibodies to the glycosyltransferases and probes for their genes will enable us to gain insight into the regulatory mechanisms leading to the apparently well-controlled glycosylation process in epithelia. The first example of such a correlation has been studied in oral epithelia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520521

Source DB:  PubMed          Journal:  APMIS Suppl        ISSN: 0903-465X


  4 in total

1.  Lewis x Antigen is Associated to Head and Neck Squamous Cell Carcinoma Survival.

Authors:  Martín E Rabassa; Adrian Pereyra; Liliana Pereyra; Amada Segal-Eiras; Martín C Abba; Maria V Croce
Journal:  Pathol Oncol Res       Date:  2017-07-05       Impact factor: 3.201

2.  Characterization of sugar receptor expression by neoglycoproteins in oral and oropharyngeal squamous cell carcinomas.

Authors:  M K Steuer; M Steuer; V Bonkowsky; H J Gabius; F Hofstädter
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

3.  Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats.

Authors:  C O Juhl; L Vinter-Jensen; S S Poulsen; T F Orntoft; E Z Dajani
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

4.  Losses of expression of the antigens A, Lea and Lex and over-expression of Ley in carcinomas and HG-SIL of the uterine cervix.

Authors:  Ernesto Moro-Rodríguez; Emilio Alvarez-Fernández
Journal:  Diagn Pathol       Date:  2008-09-11       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.